←back to thread

410 points jjulius | 4 comments | | HN request time: 0.203s | source
Show context
ivewonyoung ◴[] No.41884954[source]
> NHTSA said it was opening the inquiry after four reports of crashes where FSD was engaged during reduced roadway visibility like sun glare, fog, or airborne dust. A pedestrian was killed in Rimrock, Arizona, in November 2023 after being struck by a 2021 Tesla Model Y, NHTSA said. Another crash under investigation involved a reported injury

> The probe covers 2016-2024 Model S and X vehicles with the optional system as well as 2017-2024 Model 3, 2020-2024 Model Y, and 2023-2024 Cybertruck vehicles.

This is good, but also for context 45 thousand people are killed in auto accidents in just the US every year, making 4 report crashes and 1 reported fatality for 2.4 million vehicles over 8 years look miniscule by comparison, or even better than many human drivers.

replies(6): >>41885003 #>>41885005 #>>41885011 #>>41885014 #>>41885082 #>>41885133 #
1. insane_dreamer ◴[] No.41885082[source]
> making 4 report crashes and 1 reported fatality for 2.4 million vehicles over 8 years look miniscule by comparison,

that's the wrong comparison

the correct comparison is the number of report crashes and fatalities for __unsupervised FSD__ miles driven (not counting Tesla pilot tests, but actual customers)

replies(1): >>41885250 #
2. jandrese ◴[] No.41885250[source]
That seems like a bit of a chicken and egg problem where the software is not allowed to go unsupervised until it racks up a few million miles of successful unsupervised driving.
replies(2): >>41885493 #>>41888637 #
3. AlotOfReading ◴[] No.41885493[source]
There's a number of state programs to solve this problem with testing permits. The manufacturer puts up a bond and does testing in a limited area, sending reports on any incidents to the state regulator. The largest of these, California's, has several dozen companies with testing permits.

Tesla currently does not participate in any of these programs.

4. insane_dreamer ◴[] No.41888637[source]
Similar to a Phase 3 clinical trial (and for similar reasons).